| Serial Number | 97865808 |
| Word Mark | EYEDENTITY |
| Filing Date | Thursday, March 30, 2023 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, April 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | eye drops; eye drops for the treatment of ophthalmic disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 24, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Lenz Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Del Mar, CA 92014 |
| Event Date | Event Description |
| Thursday, April 4, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, April 4, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, December 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, December 20, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 20, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 19, 2023 | ASSIGNED TO EXAMINER |
| Monday, October 16, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 16, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 16, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 24, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 3, 2023 | NEW APPLICATION ENTERED |